Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy
| Status: | Recruiting |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | April 2015 |
| End Date: | April 2017 |
Assessment of 3D Transperineal Ultrasound Imaging With Matrix Array Transducers as a Potential Imaging Modality for Adaptive Prostate and Post-Prostatectomy Radiotherapy
SPECIFIC STUDY AIMS
1. To evaluate congruence between pelvic anatomical structures segmented on MRI and/or CT
scans co-registered with transperineal US scans acquired with an optically and/or
electromagnetically tracked matrix array ultrasound transducer.
2. To estimate the achievable accuracy of anatomy tracking based on 3D US matrix-array
transducer imaging and grey-level based image registration algorithms.
1. To evaluate congruence between pelvic anatomical structures segmented on MRI and/or CT
scans co-registered with transperineal US scans acquired with an optically and/or
electromagnetically tracked matrix array ultrasound transducer.
2. To estimate the achievable accuracy of anatomy tracking based on 3D US matrix-array
transducer imaging and grey-level based image registration algorithms.
SPECIFIC STUDY AIMS
1. To evaluate congruence between pelvic anatomical structures segmented on MRI and/or CT
scans co-registered with transperineal US scans acquired with an optically and/or
electromagnetically tracked matrix array ultrasound transducer.
2. To estimate the achievable accuracy of anatomy tracking based on 3D US matrix-array
transducer imaging and grey-level based image registration algorithms.
1. To evaluate congruence between pelvic anatomical structures segmented on MRI and/or CT
scans co-registered with transperineal US scans acquired with an optically and/or
electromagnetically tracked matrix array ultrasound transducer.
2. To estimate the achievable accuracy of anatomy tracking based on 3D US matrix-array
transducer imaging and grey-level based image registration algorithms.
Inclusion Criteria:
- Men that will undergo prostate radiotherapy as a primary treatment or
post-prostatectomy.
- Age 18 or older
- Ability to understand and sign informed consent
Exclusion Criteria:
- Younger than 18 yrs old
- Inability to provide written and spoken consent.
- Patients with implanted actively controlled devices that may be subject to
electromagnetic interference from the UroNav/PervuNav electromagnetic tracking used
in the study.
We found this trial at
1
site
Stanford, California 94305
Principal Investigator: Steven Hancock
Phone: 650-723-1423
Click here to add this to my saved trials
